MIDALGAN
MIDALGAN
Discontinued
DIN Number
00234575
Drug Class
Human
Market Date
Dec 31, 1948
Company
HC
welcker-lyster ltd., division of technilab inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00234575
AIG Number0403094001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
M02AB CAPSAICIN AND SIMILAR AGENTS
Product Specifications
Dosage FormOintment
Route of AdministrationTopical
AHFS Classification84:24.04
Health Canada Classification
ACTIVE INGREDIENTS (4)
CAPSAICIN (CAPSICUM)Active
Strength: 100 MG / 100 G
Monograph: CAPSAICIN (CAPSICUM)
GLYCOL SALICYLATEActive
Strength: 10 G / 100 G
Monograph: GLYCOL SALICYLATE
HISTAMINE DIHYDROCHLORIDEActive
Strength: 100 MG / 100 G
Monograph: HISTAMINE DIHYDROCHLORIDE
METHYL NICOTINATEActive
Strength: 1 G / 100 G
Monograph: METHYL NICOTINATE